Cargando…
MZF-1/Elk-1/PKCα is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma
Background: Protein kinase C alpha (PKCα) is a key signaling molecule in human cancer development. As a therapeutic strategy, targeting PKCα is difficult because the molecule is ubiquitously expressed in non-malignant cells. PKCα is regulated by the cooperative interaction of the transcription facto...
Autores principales: | Ye, Je-Chiuan, Hsu, Li-Sung, Tsai, Jen-Hsiang, Yang, Hsin-ling, Hsiao, Meen-Woon, Hwang, Jin-Ming, Lee, Chia-Jen, Liu, Jer-Yuh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604454/ https://www.ncbi.nlm.nih.gov/pubmed/28928894 http://dx.doi.org/10.7150/jca.20467 |
Ejemplares similares
-
MZF-1/Elk-1 Complex Binds to Protein Kinase Cα Promoter and Is Involved in Hepatocellular Carcinoma
por: Yue, Chia-Herng, et al.
Publicado: (2015) -
Correction: MZF-1/Elk-1 Complex Binds to Protein Kinase Cα Promoter and Is Involved in Hepatocellular Carcinoma
por: Yue, Chia-Herng, et al.
Publicado: (2015) -
MZF-1/Elk-1 interaction domain as therapeutic target for protein kinase Cα-based triple-negative breast cancer cells
por: Lee, Chia-Jen, et al.
Publicado: (2016) -
Protective Effects of Ocimum gratissimumAqueous Extracts on HaCaT Cells Against UVC-Induced Inhibition of Cell Viability and Migration
por: Chang, Sheng-Huang, et al.
Publicado: (2021) -
Therapeutic targeting of YY1/MZF1 axis by MZF1-uPEP inhibits aerobic glycolysis and neuroblastoma progression
por: Fang, Erhu, et al.
Publicado: (2020)